Reports for BUPRENORPHINE
Ingredient
BUPRENORPHINE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
BUTRANS 20 | 20MCG | PATCH | Resolved | 2022-05-20 | 2022-05-31 | 161051 |
BUTRANS 20 | 20MCG | PATCH | Resolved | 2022-09-06 | 2022-09-16 | 168627 |
BUTRANS 20 | 20MCG | PATCH | Resolved | 2023-02-03 | 2023-02-09 | 183517 |
BUTRANS 20 | 20MCG | PATCH | Resolved | 2023-02-03 | 2023-02-17 | 183519 |
PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-03-14 | 2017-11-23 | 2352 |
PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Avoided shortage | 2019-03-29 | 2019-05-01 | 79878 |
PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-06-11 | 2019-07-03 | 86234 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-10-03 | 2020-01-24 | 95396 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2021-05-20 | 2021-06-03 | 139725 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140363 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-BUPRENORPHINE/NALOXONE | Discontinued | 2019-09-17 | 2019-09-18 | 94044 | ||
BELBUCA | 150MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80230 |
BELBUCA | 300MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80233 |
BELBUCA | 450MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80236 |
BELBUCA | 75MCG | FILM, SOLUBLE | Discontinued | 2019-03-28 | 2019-04-02 | 79766 |
MYLAN-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94048 |
Showing 1 to 6 of 6